$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
怎么使用索坦呢?
2025-10-19 11:44:20
Check Details
国内怎么买索坦呢?
2025-10-19 11:44:20
Check Details
索坦上市后售价多少?
2025-10-19 11:44:20
Check Details
舒尼替尼治疗胃肠道间质瘤的效果怎样呢?
2025-10-19 11:44:20
Check Details
舒尼替尼是什么药品呢?
2025-10-19 11:44:20
Check Details
舒尼替尼可治疗什么病症?
2025-10-19 11:44:20
Check Details
舒尼替尼治疗肾癌疗效怎样呢?
2025-10-19 11:44:20
Check Details
舒尼替尼在国内上市了没?
2025-10-19 11:44:20
Check Details
舒尼替尼国内入医保了没?
2025-10-19 11:44:20
Check Details
舒尼替尼在国内医保给报销吗?
2025-10-19 11:44:20
Check Details
舒尼替尼的治疗效果怎样呢?
2025-10-19 11:44:20
Check Details
舒尼替尼的价格?
2025-10-19 11:44:20
Check Details
1
2
...
2202
2203
2204
2205
2206
2207
2208
...
4159
4160
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Capmatinib (Tabrecta): Generational Positioning, Adverse Effect Incidence, and Comprehensive Management
2
Dabrafenib (TAFINLAR): Indications, Adverse Effect Management, and Dose Modification Guide
3
Adagrasib (Krazati): A Complete Guide to Side-Effect Recognition and Grade-Based Management
4
Tepotinib (TEPMETKO): Complete Dosing, Side-Effect Management, and Discontinuation Guide
5
Tivozanib Dosage and Administration: Standard Dosing, Cycle Schedule, and Hepatic Impairment Adjustments
6
Vemurafenib: Mechanism of Action and Clinical Role in BRAF V600E–Targeted Therapy
7
Sotorasib (Lumakras): A Comprehensive Guide to the First KRAS G12C-Targeted Inhibitor
8
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
9
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?
10
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained
11
Belzutifan (Welireg): HIF-2α Inhibitor for VHL-Associated Tumors and Renal Cell Carcinoma — Dosing Phases, Survival Data, and Efficacy Insights
12
Pemigatinib vs. Anlotinib: Key Differences Between FGFR-Targeted Therapy and Multi-Target Anti-Angiogenic Treatment